CClinicalTrials.gg
RecruitingNCT07299474Updated Dec 23, 2025

Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures

An interventional study of Lavender Aromatherapy and Placebo Aromatherapy in Inferior Turbinate Hypertrophy, Chronic Rhinosinusitis (CRS) and Rhinitis, Vasomotor, sponsored by Cedars-Sinai Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by Cedars-Sinai Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
184
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the efficacy of lavender aromatherapy in adult patients undergoing awake otolaryngologic procedures in the outpatient clinic setting. The main questions it aims to answer are:

  • Does lavender aromatherapy help reduce anxiety and/or pain, and improve patient comfort during awake otolaryngologic procedures in the clinic?
  • Do patients subjectively find aromatherapy relaxing and/or beneficial during the procedure?

Researchers will compare lavender aromatherapy to placebo (an odorless liquid) to see if lavender aromatherapy helps improve patient comfort during their awake procedure

Participants will:

  • Have their scheduled procedure performed with lavender aromatherapy or placebo during the duration of the procedure
  • Take a short, less than 1 minute questionnaire both before and after the procedure, describing their levels of anxiety, pain and subjective impressions of the aromatherapy
02

Conditions studied

  • Inferior Turbinate Hypertrophy
  • Chronic Rhinosinusitis (CRS)
  • Rhinitis, Vasomotor
  • Thyroid Nodules
  • Vocal Fold Immobility

Browse trials for

Keywords

  • Aromatherapy
  • Otolaryngology
  • Awake procedure
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults ≥18 years old undergoing awake otolaryngologic procedures in the outpatient clinic
  • Able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Hypersensitivity to fragrances
  • Taking systemic NSAIDs or other systemic pain-relieving medications within 48 hours
  • Taking anxiolytics, hypnotics, sedating antihistamines, antidepressants on regular basis within 4 weeks
  • Pregnant or breastfeeding
  • Participation in another clinical research study within the prior 30 days
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
184 participants (estimated)

Study arms

  • Experimental
    Lavender Aromatherapy

    Participants will be exposed to lavender aromatherapy on a cotton ball prior to procedure, and then with a diffuser during the duration of the procedure

    Other: Lavender Aromatherapy

  • Placebo comparator
    Placebo

    Participants will be exposed to placebo odorless liquid, on a cotton ball prior to procedure, and then with a diffuser during the duration of the procedure

    Other: Placebo Aromatherapy

Interventions

  • OtherLavender Aromatherapy

    Lavender essential oil on cotton ball, and in aromatherapy diffuser

  • OtherPlacebo Aromatherapy

    Saline on cotton ball and in aromatherapy diffuser

05

What researchers measure

Primary outcomes

  1. Change in visual analog scale anxiety, measured on a 10 cm scale

    A 10 cm visual analog scale is widely utilized to measure procedural anxiety, rated from 0 to 10, with 10 being the highest level of anxiety. The patient will provide a vertical mark above their level of anxiety. This number measured in mm (0-100) will be recorded both immediately before the procedure, and after the procedure, where the patient will record their average level of anxiety during the procedure. The change between pre-procedure, and post-procedure, will be recorded for each patient and compared between the lavender aromatherapy and placebo groups. The mean and median pre-procedure and post-procedure values will also be compared between the groups.

    Time frame: Baseline, Periprocedural and Immediately after the procedure

  2. Likert scale of pain, measured on a scale of 0-10

    Patients will be asked to rate their your average level of pain on a scale of 0 (no pain) to 10 (worst possible pain) on a post-procedural questionnaire

    Time frame: Immediately after the procedure

  3. Likert scale subjective improvement with pain, measured on scale of 1-5

    Patients will be asked in post-procedural questionnaire if they felt the aromatherapy helped with pain during the procedure, on a scale of 1 (strongly disagree) to 5 (strongly agree)

    Time frame: Immediately after the procedure

Secondary outcomes

  1. Subjective Impressions of Lavender Aromatherapy, measured on Likert scale and in Yes/No format in post-procedural questionnaire

    Patients will be asked in a post-procedural questionnaire their subjective impressions of the lavender aromatherapy or placebo. The questions will be outlined as below: Did you feel the aromatherapy was calming during the procedure? 1 2 3 4 5 (1 = strongly disagree, 5 = strongly agree) Did you find the scent pleasant? 1 2 3 4 5 (1 = strongly disagree, 5 = strongly agree) Do you use aromatherapy or essential oils regularly? Yes No Have you ever used aromatherapy or essential oils in the past? Yes No How likely are you to recommend the aromatherapy for future patients undergoing awake procedures? 1 2 3 4 5 (1 = strongly disagree, 5 = strongly agree)

    Time frame: Immediately after the procedure

06

Study locations

1 of 1 sites recruiting
  • Cedars-Sinai Medical Center Otolaryngology Clinics
    Los Angeles, California 90048, United States
    Recruiting
07

References and documents

Publications

  • Braden R, Reichow S, Halm MA. The use of the essential oil lavandin to reduce preoperative anxiety in surgical patients. J Perianesth Nurs. 2009 Dec;24(6):348-55. doi: 10.1016/j.jopan.2009.10.002. PubMed 19962101 ↗
  • Kothari DS, Nieri CA, Tanenbaum ZG, Linker LA, Rangarajan SV. Mind-Body Therapies in the Management of Otolaryngologic Disease: A State-of-the-Art Review of Randomized Controlled Trials. Otolaryngol Head Neck Surg. 2024 Jan;170(1):45-60. doi: 10.1002/ohn.523. Epub 2023 Sep 15. PubMed 37712305 ↗
  • Grunebaum LD, Murdock J, Castanedo-Tardan MP, Baumann LS. Effects of lavender olfactory input on cosmetic procedures. J Cosmet Dermatol. 2011 Jun;10(2):89-93. doi: 10.1111/j.1473-2165.2011.00554.x. PubMed 21649812 ↗
  • Wotman M, Levinger J, Leung L, Kallush A, Mauer E, Kacker A. The Efficacy of Lavender Aromatherapy in Reducing Preoperative Anxiety in Ambulatory Surgery Patients Undergoing Procedures in General Otolaryngology. Laryngoscope Investig Otolaryngol. 2017 Nov 8;2(6):437-441. doi: 10.1002/lio2.121. eCollection 2017 Dec. PubMed 29299520 ↗

Individual participant data

Plan to share: No — IPD will not be shared with other researchers in order to protect patient privacy, as these patients will be undergoing awake procedures at only 1 location, and thus their results may be identified even after anonymization or de-identification.

08

Registry details

Key details

Study ID
NCT07299474
Lead sponsor
Cedars-Sinai Medical Center
Responsible party
Ankona Ghosh (Principal Investigator, Cedars-Sinai Medical Center) — Principal investigator
First posted
Dec 23, 2025
Start date
Dec 2025 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Dec 23, 2025

Study contacts

Dhruv S Kothari, MD
Contact
dhruv.kothari@cshs.org
310-560-7331
Ankona Ghosh, MD
Contact
ankona.ghosh@cshs.org
213-300-7972
Ankona Ghosh, MD
principal investigator · Cedars-Sinai Medical Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion